In this assay, the viral ability to agglutinate red blood cells (common feature of influenza virus) is tested. If your API blocks this interaction, it demonstrates its ability to neutralize the virus and prevent viral attachment to host cells.
This assay is commonly used for influenza virus and other RNA viruses to determine how effectively a compound can prevent viral entry into host cells, which is a critical early step in infection.